Julia Y. Tsang
State Key Laboratory Of Translational Oncology
Sha Tin, NST, Hong Kong Special Administrative Region
Sha Tin, NST, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Comparison of Claudin-4, BerEP4, Carcinoembryonic Antigen and MOC31 in Serous Fluids Metastases Demonstrate High Sensitivity of Claudin-4 at Low Cellularity.
Journal: Diagnostic cytopathology
Published: June 29, 2024
Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 23, 2024
TRPS1 is a promising marker for all subtypes of breast cancer.
Journal: Histopathology
Published: July 31, 2023
Spatial Distribution and Densities of CD103+ and FoxP3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in Breast Cancer.
Journal: The oncologist
Published: December 31, 2022
Anatomical site and size of sentinel lymph node metastasis predicted additional axillary tumour burden and breast cancer survival.
Journal: Histopathology
Published: September 02, 2022
Fine needle aspiration cytology of metastatic carcinomas with papillary architecture: A systemic assessment of clinical, cytological and immunohistochemical parameters.
Journal: Cytopathology : official journal of the British Society for Clinical Cytology
Published: October 30, 2021
Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer: author reply.
Journal: Pathology
Published: November 30, 2020
Papillary lesions of the breast: A systematic evaluation of cytologic parameters.
Journal: Cancer cytopathology
Published: August 01, 2020
The significance of highlighting the oestrogen receptor low category in breast cancer.
Journal: British journal of cancer
Published: March 25, 2020
Axillary Nodal Metastasis with Papillary Morphology: An Uncommon Origin.
Journal: Acta cytologica
Published: December 06, 2019
Is Danggui Safe to be Taken by Breast Cancer Patients?-A Skepticism Finally Answered by Comprehensive Preclinical Evidence.
Journal: Frontiers in pharmacology
Published: March 12, 2019
Last Updated: 09/26/2026